Latest Conference Articles

Elinzanetant Update: Phase 3 Findings Published in JAMA with PDUFA Date Set for October 26

Elinzanetant Update: Phase 3 Findings Published in JAMA with PDUFA Date Set for October 26

September 19th 2025

The Menopause Society Annual Meeting

If approved, the nonhormonal drug could offer an important new option for postmenopausal women seeking alternatives to hormone therapy.

FDA Updates Albuterol/Budesonide Label to Include Evidence of Exacerbation Risk Reduction in Mild Asthma

FDA Updates Albuterol/Budesonide Label to Include Evidence of Exacerbation Risk Reduction in Mild Asthma

September 18th 2025

FMX

The updated prescribing information includes phase 3b BATURA trial results showing a 46% reduction in severe exacerbations in mild asthma vs albuterol.

Most Parents Trust Standard Childhood Vaccines, but Many Question Flu and COVID-19 Shots: KFF-Washington Post Survey

Most Parents Trust Standard Childhood Vaccines, but Many Question Flu and COVID-19 Shots: KFF-Washington Post Survey

September 15th 2025

FMX

Most parents support childhood vaccines such as MMR and polio, but skepticism about seasonal and newer shots persists, along with distrust of federal agencies.

Real-World Data Support Effectiveness of Neffy (epinephrine nasal spray) for Acute Treatment of Anaphylaxis

Real-World Data Support Effectiveness of Neffy (epinephrine nasal spray) for Acute Treatment of Anaphylaxis

September 15th 2025

FMX

A single dose of neffy was effective in nearly 90% of patients treated for anaphylactic reactions during oral food challenge and allergen immunotherapy.

Family Physician to Colleagues: Please, Value Your Own Mental Health

Family Physician to Colleagues: Please, Value Your Own Mental Health

September 12th 2025

FMX

Teresa Lovins, MD, talked with Patient Care about suicidal ideation among patients and then focused on asking her colleagues to make their own mental health a priority.

A Family Physician on When to Manage Depression in Primary Care—and When to Refer

A Family Physician on When to Manage Depression in Primary Care—and When to Refer

September 9th 2025

FMX

Family physician Teresa Lovins, MD, explains how primary care clinicians can determine when to manage depression and when urgent referral is needed.

How to Talk to Patients About Respiratory Virus Vaccines This Year? The Same Way We Always Do

How to Talk to Patients About Respiratory Virus Vaccines This Year? The Same Way We Always Do

August 20th 2025

FMX

William Schaffner, MD, advises first and foremost to stay away from politics, to acknowledge and normalize patient fear and concern, and to answer quickly and with confidence.

Back-to-School Pediatric Vaccination: A Family Physician’s Perspective on Boosting Rates, Countering Misinformation

Back-to-School Pediatric Vaccination: A Family Physician’s Perspective on Boosting Rates, Countering Misinformation

August 19th 2025

FMX

Sarah Sams, MD, emphasizes education, empathy, and proactive communication to support families and protect public health.

Primary Care Needs the Right Tools to Identify MCI Early, Says Rodney Swenson, PhD

Primary Care Needs the Right Tools to Identify MCI Early, Says Rodney Swenson, PhD

August 6th 2025

FMX

If primary care clinicians are to meet the cognitive screening demands that are growing with an aging population, they need the sharpest tools in the box, this expert says.

FDA Extends Review Period for Elinzanetant NDA for Menopausal Vasomotor Symptoms

FDA Extends Review Period for Elinzanetant NDA for Menopausal Vasomotor Symptoms

July 25th 2025

The Menopause Society Annual Meeting

Bayer's elinzanetant, a potential nonhormonal treatment for menopausal symptoms, awaits FDA approval after a 90-day review extension.